Fluticasone propionate not checked

HALEON

FollowEvery change as it happens, and a Monday email
Stage
in the US
Next date
Phase 4 trial completes
Trials
1 active
1 in total

What this is

How it works
A steroid that calms inflammation and the immune system.Corticosteroid FDA class
How it’s given
“Fluticasone propionate aqueous nasal spray (United States Pharmacopeia \[USP\]), 50 microgram (mcg)/metered spray.”In the company’s words, NCT07817134 on ClinicalTrials.gov
Tested for
Rhinitis Allergic, Rhinitis Seasonal
Main trialPhase 4
“This study is designed to visualize the response to use of fluticasone propionate nasal spray (Flonase Allergy Relief) to relieve facial allergy symptoms in individuals with moderate to severe seasonal allergic rhinitis (SAR).”In the company’s words, NCT07817134 on ClinicalTrials.gov

Other drugs for Rhinitis Allergic

All 5 drugs for Rhinitis Allergic

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 4Not yet recruiting Dec 2026 A Study to Visualize Multi-Symptom Allergy in Adults With Seasonal Allergic Rhinitis
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Fluticasone propionate

Following is part of Solo: you see every change to Fluticasone propionate the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in